NeogenTC
PrivateLast Round
Series B
Feb 1, 2024
Total Funding Raised
$19.52M
Company Overview
NeogenTC is a biotechnology company that develops personalized anti-cancer immune T-cell therapies based on a novel antigen discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeogenTC Comparables
Compare NeogenTC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Juncell Therapeutics Co., Ltd. | 87% | |
| Grit Biotherapeutics | 86% | |
| Obsidian Therapeutics | 83% |
NeogenTC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 1, 2024 | ||||
| Series A | Apr 6, 2021 | ||||
| Seed | Dec 1, 2020 |
NeogenTC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series A |
| DSC Investment | Series A |
| Bluepoint Partners | Seed |
| TS Investment | Series A |
| LogInvestment | Series A |
| Tcha Partners Asset Management | Series A |
| QUAD Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 79% to 3,000.
- Jun 1, 2025
Monthly visitors increased 42% MoM.
NeogenTC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeogenTC's valuation, stock price, and market status.
Is NeogenTC a public or private company?
NeogenTC is a private company.
What is the current stock price of NeogenTC?
NeogenTC is a private company with no public stock price. Caplight tracks NeogenTC's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is NeogenTC worth (valuation)?
Valuation information for NeogenTC is not publicly available.
Can I buy NeogenTC stock?
NeogenTC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeogenTC's last funding round?
NeogenTC's most recent funding round was Series B on February 1, 2024.
Who are the main investors in NeogenTC?
Key investors in NeogenTC include Seoul Investment Partners, DSC Investment, Bluepoint Partners, TS Investment, LogInvestment.
Will NeogenTC IPO soon?
No public IPO plans have been announced for NeogenTC.
How can I track NeogenTC secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeogenTC's secondary market activity and sign up for updates.